Page last updated: 2024-09-04

atazanavir sulfate and Pregnancy

atazanavir sulfate has been researched along with Pregnancy in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (19.05)	29.6817
2010's	30 (71.43)	24.3611
2020's	4 (9.52)	2.80

Authors

Authors	Studies
Badell, ML; Best, BM; Browning, R; Capparelli, EV; Chakhtoura, N; Denson, K; George, K; Mirochnick, M; Momper, JD; Paul, ME; Powis, KM; Rungruengthanakit, K; Shapiro, DE; Stek, A; Wang, J	1
Brummel, SS; Chadwick, EG; Huo, Y; Jacobson, DL; Jao, J; Kacanek, D; Kahlert, CR; Patel, K; Powis, KM; Seage, GR; Shiau, S; Sultan-Beyer, L; Williams, PL; Yee, LM; Zash, R	1
Avelino-Silva, VI; Fonseca, FF; Pascom, ARP; Pereira, G; Perini, FB; Pinho, RGG	1
Acosta, S; Balogun, K; Guzman Lenis, MS; Mount, HT; Sarkar, A; Serghides, L	1
Chatelut, E; Delobel, P; Gandia, P; Metsu, D; Toutain, PL	1
Bonito, A; Bonora, S; Calcagno, A; Casari, S; Castelli, F; D'Avolio, A; Di Perri, G; Domenighini, E; Focà, E; Quiros Roldan, E; Simiele, M; Trentini, L	1
Cetin, I; Dalzero, S; Degli Antoni, A; Floridia, M; Francisci, D; Frisina, V; Liuzzi, G; Maccabruni, A; Masuelli, G; Ravizza, M; Sansone, M; Simonazzi, G; Tamburrini, E; Tassis, B	1
Bonito, A; Bonora, S; Calcagno, A; Castelli, F; Castelnuovo, F; Cusato, J; D'Avolio, A; Di Perri, G; Domenighini, E; Focà, E; Quiros Roldan, E; Trentini, L	1
Cerveny, L; Durisova, M; Ptackova, Z; Staud, F	1
Bertz, R; Botes, M; Conradie, F; Eley, T; Hardy, H; Huang, SP; Josipovic, D; McGrath, D; Osiyemi, O; Zorrilla, CD	1
Atrio, JM; Chen, KT; Posada, R; Rodriguez Caprio, G; Sperling, RS	1
Degli Antoni, A; Fiscon, M; Floridia, M; Francisci, D; Giacomet, V; Liuzzi, G; Marconi, AM; Martinelli, P; Masuelli, G; Pinnetti, C; Ravizza, M; Spinillo, A; Tamburrini, E	1
Haberl, A; Johnson, M; Walmsley, S	1
Back, DJ; Brennan, M; Coulter-Smith, S; Else, LJ; Jackson, V; Khoo, SH; Lambert, JS	1
Burger, D; Colbers, A; Giaquinto, C; Gingelmaier, A; Hawkins, D; Hidalgo-Tenorio, C; Ivanovic, J; Kabeya, K; Lambert, J; Moltó, J; Rockstroh, J; Sadiq, ST; Taylor, G; van der Ende, M; Weizsäcker, K; Wyen, C	1
Anderson, J; Bradshaw, D; Brook, G; Byrne, L; Chan, SY; de Ruiter, A; Dhairyawan, R; Hawkins, D; Hay, P; Mandalia, S; Naftalin, C; Natha, M; Noble, H; Offodile, N; Perry, M; Poulton, M; Rodgers, M; Roedling, S; Samuel, M; Sarner, L; Shah, R; Short, CE; Smith, K; Taylor, G; Zhou, J	1
Arnold, M; Cojocaru, L; Demers, R; Eley, T; Rose, A; Ryan, J; Stouffer, B; Xu, XS	1
Bourgeois-Moine, A; Bourse, P; Calvez, V; Damond, F; Descamps, D; Dommergues, M; Duro, D; Faucher, P; Ichou, H; Landman, R; Lariven, S; Lê, MP; Legac, S; Mandelbrot, L; Matheron, S; Meier, F; Mortier, E; Peytavin, G; Soulié, C; Tubiana, R; Valantin, MA	1
Amiel, C; Caseris, M; Charpentier, C; Descamps, D; Desnoyer, A; Farnoux, C; Lassel, L; Lê, MP; Pain, JB; Peytavin, G; Pialoux, G	1
Frederick, T; Hazra, R; Himes, SK; Huestis, MA; Huo, Y; Rice, ML; Siberry, GK; Sirois, PA; Williams, PL	1
Armstrong, DA; Brummel, SS; Kacanek, D; Lester, BM; Marsit, CJ; Rich, K; Seage, GR; Spector, SA	1
Anderson, J; Barbour, A; Conway, K; Dermont, S; deRuiter, A; Dwyer, E; Flanagan, S; Hawkins, D; Hay, P; McKendry, A; Mulka, L; Perry, ME; Rodgers, M; Roedling, S; Sabin, CA; Sarner, L; Shah, R; Stevenson, J; Taylor, GP; Williams, E; Wood, C	1
Caniglia, EC; Hernán, MA; Hernandez-Diaz, S; Huo, Y; Jacobson, DL; Kapetanovic, S; Patel, K; Rich, KC; Seage, GR; Sirois, PA; Williams, PL	1
Barr, E; Davies, J; Forster, JE; Kinzie, K; Levin, MJ; McFarland, EJ; Pappas, J; Paul, S; Smith, C; Weinberg, A	1
Apornpong, T; Avihingsanon, A; Banchongkit, S; Bhakeecheep, S; Bowonwatanuwong, C; Bunupuradah, T; Chaivooth, S; Chetchotisakd, P; Cooper, DA; Emery, S; Jirajariyavej, S; Kantipong, P; Kerr, SJ; Kiertiburanakul, S; Klinbuayaem, V; Leerattanapetch, N; Mekviwattanawong, S; Munsakul, W; Nimitvilai, S; Phanuphak, P; Prasithsirikul, W; Ruxrungtham, K; Techapornroong, M	1
Cattaneo, D; Maggiolo, F; Perico, N; Ripamonti, D	1
Wood, R	1
Lötsch, J; von Hentig, N	1
Anceschi, MM; Ascenzi, P; Ivanovic, J; Mattia, E; Narciso, P; Nicastri, E; Notari, S; Pisani, G; Pucillo, LP; Signore, F; Tempestilli, M; Vallone, C	1
López-Cortés, LF	1
Antela López, A	1
Basar, M; Best, BM; Burchett, SK; Capparelli, EV; Hawkins, E; Hu, C; Mirochnick, M; Read, JS; Rossi, SS; Smith, E; Stek, AM	1
Azria, E; Crenn-Hebert, C; Ferreira, C; Floch-Tudal, C; Herinomenzanahary, E; Mandelbrot, L; Mazy, F; Meier, F; Peytavin, G; Treluyer, JM	1
Bertz, R; Botes, M; Child, M; Conradie, F; Eley, T; Hu, W; Josipovic, D; McGrath, D; Osiyemi, O; Vandeloise, E; Wirtz, V; Zorrilla, C	1
Albano, J; Arikan, D; Esker, S; Jimenez-Exposito, MJ; Seekins, D; Tilson, H; Uy, J	1
Focà, E; Motta, D; Ripamonti, D; Torti, C	1
Cauda, R; Ciccarelli, N; Cingolani, A; Colafigli, M; D'Avino, A; De Luca, A; Di Giambenedetto, S; Fabbiani, M; Farina, S; Mondi, A; Murri, R; Navarra, P; Sidella, L; Tamburrini, E	1
Best, BM; Burchett, SK; Byroads, M; Caparelli, E; Cressey, TR; Hawkins, E; Kreitchmann, R; Mirochnick, M; Rossi, S; Shapiro, DE; Smith, E; Stek, A; Wang, J; Watts, DH	1
Clarke, A; de Ruiter, A; Issa, R; Lechelt, M; Lyons, F; Magaya, V	1
Airoldi, M; Bertuletti, P; Cattaneo, D; Frigerio, L; Maggiolo, F; Ripamonti, D; Ruggeri, M; Suter, F	1

Reviews

4 review(s) available for atazanavir sulfate and Pregnancy

Article	Year
A systematic review of the use of atazanavir in women infected with HIV-1. Antiviral therapy, 2014, Volume: 19, Issue:3 Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Oligopeptides; Pregnancy; Pyridines; Ritonavir; Sex Factors; Treatment Outcome; Viral Load	2014
Atazanavir: its role in HIV treatment. Expert review of anti-infective therapy, 2008, Volume: 6, Issue:6 Topics: Anti-HIV Agents; Atazanavir Sulfate; Drug Interactions; Female; HIV Infections; HIV Protease Inhibitors; Humans; Oligopeptides; Pregnancy; Pyridines	2008
[Pharmacology, pharmacokinetic features and interactions of atazanavir]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 17 Topics: Anti-HIV Agents; Atazanavir Sulfate; Biological Availability; Biotransformation; Blood Proteins; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Fetal Blood; Glucuronosyltransferase; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Infant, Newborn; Kidney Diseases; Liver Diseases; Maternal-Fetal Exchange; Metabolic Clearance Rate; Molecular Structure; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pyridines	2008
[Utility of atazanavir in special populations]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 17 Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cardiovascular Diseases; Child; Child, Preschool; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; Emigrants and Immigrants; Female; Heroin Dependence; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Hyperbilirubinemia, Neonatal; Infant; Infant, Newborn; Insulin Resistance; Kidney Diseases; Liver Diseases; Male; Methadone; Multicenter Studies as Topic; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyridines; Young Adult	2008

Trials

7 trial(s) available for atazanavir sulfate and Pregnancy

Article	Year
Clinical and pharmacogenetic factors affecting neonatal bilirubinemia following atazanavir treatment of mothers during pregnancy. AIDS research and human retroviruses, 2013, Volume: 29, Issue:10 Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Bilirubin; Female; Glucuronosyltransferase; HIV Infections; Humans; Hyperbilirubinemia; Infant, Newborn; Oligopeptides; Plasma; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyridines; Ritonavir	2013
Atazanavir exposure is effective during pregnancy regardless of tenofovir use. Antiviral therapy, 2015, Volume: 20, Issue:1 Topics: Adolescent; Adult; Area Under Curve; Atazanavir Sulfate; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Gestational Age; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Pregnancy; Pregnancy Trimester, Third; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Tenofovir; Treatment Outcome; Viral Load	2015
Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial. The lancet. HIV, 2016, Volume: 3, Issue:8 Topics: Adolescent; Adult; Atazanavir Sulfate; Dose-Response Relationship, Drug; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Pregnancy; Ritonavir; Thailand; Viral Load; Young Adult	2016
Atazanavir pharmacokinetics with and without tenofovir during pregnancy. Journal of acquired immune deficiency syndromes (1999), 2011, Apr-15, Volume: 56, Issue:5 Topics: Adenine; Anti-HIV Agents; Atazanavir Sulfate; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infectious Disease Transmission, Vertical; Oligopeptides; Organophosphonates; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Prospective Studies; Pyridines; Reverse Transcriptase Inhibitors; Ritonavir; Tenofovir; Treatment Outcome	2011
Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women. HIV medicine, 2011, Volume: 12, Issue:9 Topics: Adult; Atazanavir Sulfate; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infectious Disease Transmission, Vertical; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Puerto Rico; Pyridines; Ritonavir; South Africa; United States; Viral Load	2011
Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy. Journal of acquired immune deficiency syndromes (1999), 2013, May-01, Volume: 63, Issue:1 Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Atazanavir Sulfate; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Oligopeptides; Organophosphonates; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Pyridines; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Young Adult	2013
Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer. AIDS (London, England), 2007, Nov-30, Volume: 21, Issue:18 Topics: Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Monitoring; Female; Fetal Blood; HIV Infections; HIV Protease Inhibitors; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Maternal-Fetal Exchange; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyridines; Ritonavir	2007

Other Studies

31 other study(ies) available for atazanavir sulfate and Pregnancy

Article	Year
Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV. Journal of acquired immune deficiency syndromes (1999), 2022, 03-01, Volume: 89, Issue:3 Topics: Anti-HIV Agents; Atazanavir Sulfate; Child; Cobicistat; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infectious Disease Transmission, Vertical; Placenta; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies	2022
Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States. The New England journal of medicine, 2022, 09-01, Volume: 387, Issue:9 Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Cobicistat; Cohort Studies; Darunavir; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Oxazines; Piperazines; Pregnancy; Premature Birth; Pyridones; Quinolones; Raltegravir Potassium; Rilpivirine; Ritonavir; United States	2022
Impact of antiretroviral regimen on viral suppression among pregnant women living with HIV in Brazil. International journal of STD & AIDS, 2020, Volume: 31, Issue:9 Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Brazil; Cyclopropanes; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Raltegravir Potassium; Treatment Outcome; Viral Load	2020
In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice. PloS one, 2020, Volume: 15, Issue:11 Topics: Animals; Anti-HIV Agents; Atazanavir Sulfate; Developmental Disabilities; Dideoxynucleosides; Emtricitabine; Exploratory Behavior; Female; Fetal Growth Retardation; Growth Disorders; Hand Strength; HIV Protease Inhibitors; Homing Behavior; Lamivudine; Male; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Reflex, Abnormal; Reflex, Righting; Sensation Disorders; Taxis Response; Tenofovir	2020
Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle? The Journal of antimicrobial chemotherapy, 2017, 09-01, Volume: 72, Issue:9 Topics: Atazanavir Sulfate; Blood Proteins; Darunavir; Dose-Response Relationship, Drug; Female; Hepatocytes; HIV Infections; HIV Protease Inhibitors; Humans; Pregnancy; Protein Binding	2017
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients. The Journal of antimicrobial chemotherapy, 2017, Nov-01, Volume: 72, Issue:11 Topics: Adult; Atazanavir Sulfate; CD4 Lymphocyte Count; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infant, Newborn; Leukocytes, Mononuclear; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimesters; Prospective Studies; Ritonavir; RNA, Viral; Tenofovir; Viral Load	2017
Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study. The Journal of antimicrobial chemotherapy, 2018, 04-01, Volume: 73, Issue:4 Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Atazanavir Sulfate; Bilirubin; Cholesterol; Darunavir; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Treatment Outcome; Triglycerides; Viral Load	2018
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-Ritonavir. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:7 Topics: Adult; Atazanavir Sulfate; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Liver-Specific Organic Anion Transporter 1; Polymorphism, Single Nucleotide; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Pregnane X Receptor; Prospective Studies; Ritonavir	2018
Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: Effect on transplacental disposition in rats. Reproductive toxicology (Elmsford, N.Y.), 2018, Volume: 79 Topics: Animals; Atazanavir Sulfate; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; Dogs; Drug Interactions; Female; HIV Protease Inhibitors; Madin Darby Canine Kidney Cells; Maternal-Fetal Exchange; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Placenta; Pregnancy; Rats, Wistar; Ritonavir	2018
Maternal atazanavir usage in HIV-infected pregnant women and the risk of maternal and neonatal hyperbilirubinemia. Journal of acquired immune deficiency syndromes (1999), 2013, Aug-15, Volume: 63, Issue:5 Topics: Anti-HIV Agents; Atazanavir Sulfate; Female; HIV Infections; Humans; Hyperbilirubinemia; Infant, Newborn; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Prevalence; Pyridines; Risk Assessment	2013
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:5 Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Lipids; Liver Function Tests; Lopinavir; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyridines; RNA, Viral; Viral Load	2014
Therapeutic drug monitoring of atazanavir/ritonavir in pregnancy. HIV medicine, 2014, Volume: 15, Issue:10 Topics: Adult; Analysis of Variance; Anti-HIV Agents; Atazanavir Sulfate; Drug Monitoring; Female; HIV Infections; HIV Protease Inhibitors; Humans; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pyridines; Ritonavir; Young Adult	2014
Antenatal atazanavir: a retrospective analysis of pregnancies exposed to atazanavir. Infectious diseases in obstetrics and gynecology, 2014, Volume: 2014 Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Female; HIV Infections; Humans; Infectious Disease Transmission, Vertical; London; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; Pyridines; Retrospective Studies; Viral Load	2014
Quantitative determination of free/bound atazanavir via high-throughput equilibrium dialysis and LC-MS/MS, and the application in ex vivo samples. Bioanalysis, 2014, Volume: 6, Issue:23 Topics: Anti-HIV Agents; Atazanavir Sulfate; Blood Chemical Analysis; Chromatography, Liquid; Clinical Trials as Topic; Dialysis; Female; Humans; Oligopeptides; Pregnancy; Protein Binding; Pyridines; Reproducibility of Results; Tandem Mass Spectrometry	2014
Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women. Antiviral therapy, 2015, Volume: 20, Issue:5 Topics: Adult; Atazanavir Sulfate; CD4 Lymphocyte Count; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Female; HIV Protease Inhibitors; HIV-1; Humans; Hyperbilirubinemia; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Ritonavir; Viral Load	2015
Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:6 Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Cytochrome P-450 CYP3A; Emtricitabine; Female; Glucuronosyltransferase; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Infant, Newborn; Male; Oxazines; Piperazines; Pregnancy; Pyridones; Ritonavir; Tenofovir	2015
Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure. Journal of acquired immune deficiency syndromes (1999), 2015, Jun-01, Volume: 69, Issue:2 Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Chromatography, Liquid; Female; HIV Infections; Humans; Infant; Infant, Newborn; Language Development; Male; Maternal-Fetal Exchange; Meconium; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Pyridines; Tandem Mass Spectrometry	2015
Infant peripheral blood repetitive element hypomethylation associated with antiretroviral therapy in utero. Epigenetics, 2015, Volume: 10, Issue:8 Topics: Adult; Alu Elements; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; DNA Methylation; Epigenesis, Genetic; Female; HIV; HIV Infections; Humans; Infant, Newborn; Long Interspersed Nucleotide Elements; Mother-Child Relations; Pregnancy	2015
Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates. HIV medicine, 2016, Volume: 17, Issue:1 Topics: Adolescent; Adult; Atazanavir Sulfate; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Infant, Newborn; Lopinavir; Middle Aged; Pregnancy; Pregnancy Outcome; Premature Birth; Retrospective Studies; Ritonavir; Treatment Outcome; Viral Load; Young Adult	2016
Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study. AIDS (London, England), 2016, 05-15, Volume: 30, Issue:8 Topics: Adult; Atazanavir Sulfate; Female; Fetal Development; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Infant, Newborn; Male; Nervous System; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Prospective Studies; Young Adult	2016
Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir. Infectious diseases in obstetrics and gynecology, 2016, Volume: 2016 Topics: Atazanavir Sulfate; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Infant, Newborn; Infant, Newborn, Diseases; Lopinavir; Male; Nelfinavir; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Retrospective Studies; Ritonavir	2016
[HIV infection and pregnancy. Improved therapy management for HIV infected pregnant patients]. MMW Fortschritte der Medizin, 2016, Jun-09, Volume: 158 Suppl 1 Topics: Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Female; Germany; Guideline Adherence; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Middle Aged; Pregnancy; Pregnancy Complications, Infectious	2016
Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detection. Journal of chromatographic science, 2008, Volume: 46, Issue:6 Topics: Atazanavir Sulfate; Calibration; Chromatography, High Pressure Liquid; Female; HIV Protease Inhibitors; Humans; Oligopeptides; Pregnancy; Pyridines; Reference Standards; Sensitivity and Specificity; Spectrophotometry, Ultraviolet	2008
Cytochrome P450 3A inhibition by atazanavir and ritonavir, but not demography or drug formulation, influences saquinavir population pharmacokinetics in human immunodeficiency virus type 1-infected adults. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Adult; Age Factors; Aged; Atazanavir Sulfate; Cytochrome P-450 CYP3A Inhibitors; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Oligopeptides; Pregnancy; Pyridines; Ritonavir; Saquinavir; Sex Factors; Young Adult	2009
Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women. Current HIV research, 2009, Volume: 7, Issue:6 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Apgar Score; Atazanavir Sulfate; Birth Weight; Female; Gestational Age; HIV Infections; Humans; Infant, Newborn; Lopinavir; Maternal-Fetal Exchange; Nelfinavir; Nevirapine; Oligopeptides; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyridines; Pyrimidinones	2009
Atazanavir in pregnancy: impact on neonatal hyperbilirubinemia. European journal of obstetrics, gynecology, and reproductive biology, 2011, Volume: 157, Issue:1 Topics: Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Bilirubin; Cohort Studies; Female; Fetal Blood; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia, Neonatal; Infant, Newborn; Jaundice, Neonatal; Male; Maternal-Fetal Exchange; Medical Records; Oligopeptides; Phototherapy; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Pyridines; Retrospective Studies; Ritonavir	2011
FDA notifications. FDA approves new atazanavir labeling. AIDS alert, 2011, Volume: 26, Issue:3 Topics: Atazanavir Sulfate; Contraindications; Drug Approval; Drug Interactions; Female; HIV Protease Inhibitors; Humans; Oligopeptides; Pregnancy; Pyridines; United States; United States Food and Drug Administration	2011
Monitoring the risk of birth defects associated with atazanavir exposure in pregnancy. AIDS patient care and STDs, 2012, Volume: 26, Issue:6 Topics: Abnormalities, Drug-Induced; Adult; Anti-HIV Agents; Atazanavir Sulfate; Data Collection; Female; HIV Infections; Humans; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Pyridines; Registries; Retrospective Studies; Young Adult	2012
Unboosted atazanavir for treatment of HIV infection: rationale and recommendations for use. Drugs, 2012, Jun-18, Volume: 72, Issue:9 Topics: Anti-HIV Agents; Atazanavir Sulfate; Drug Interactions; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Male; Oligopeptides; Patient Selection; Practice Guidelines as Topic; Pregnancy; Pyridines; Randomized Controlled Trials as Topic; Risk Factors	2012
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir an The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:6 Topics: Adiposity; Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Body Composition; Bone and Bones; Cognition; Drug Resistance, Viral; Endpoint Determination; Female; Glomerular Filtration Rate; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lamivudine; Male; Middle Aged; Neuropsychological Tests; Oligopeptides; Patient Compliance; Pilot Projects; Pregnancy; Pyridines; Quality of Life; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Treatment Failure	2013
Human placental transfer of atazanavir: a case report. AIDS (London, England), 2006, Jan-09, Volume: 20, Issue:2 Topics: Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Female; HIV Infections; HIV Protease Inhibitors; Humans; Maternal-Fetal Exchange; Oligopeptides; Pregnancy; Pregnancy Complications, Infectious; Pyridines	2006